Scientist Home Future Health Ltd (SHFH) KPIs and segments
Close on Oct 19, 2026Market cap $40.32MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Scientist Home Future Health's business
Scientist Home Future Health's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Retail Trading Business($M) | 0.08 | 0.18 | 0.08 | 0.04 | 0.03 | 0.04 | ||||
Service Business($M) | 0.00 | 0.01 | ||||||||
Scientist Home Cholipolysis Cholic Acid($M) | 0.03 | 0.02 | 0.04 | |||||||
Scientist Home Mixed Gelatine Hydrolysate($M) | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |||
Scientist Home High Concentration Proteinase($M) | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||
Scientist Home Immune Study($M) | 0.01 | 0.01 | 0.02 | |||||||
Others (Delivery Fee)($M) | 0.01 | 0.04 | 0.09 | 0.05 | 0.00 | 0.00 | 0.00 | |||
Lipolysis And Fat Reduction Research($M) | 0.01 | |||||||||
Mixed Gelatine Hydrolysate($M) | 0.01 | |||||||||
Hydrolyzed Collagen Member($M) | 0.01 | |||||||||
Iron Heavy Metals Chelation($M) | 0.01 | |||||||||
Scientist Home Fibrosis Study($M) | 0.01 | 0.00 | 0.01 | |||||||
Scientist Home Chelation Study($M) | 0.01 | 0.00 | 0.01 | |||||||
Enzyme and Coenzyme Research($M) | 0.01 | |||||||||
Neurological Study($M) | 0.01 | |||||||||
Matrine Propolis($M) | 0.01 | |||||||||
Regulatory T Cells Research($M) | 0.01 | |||||||||
Scientist Home Bone Gelatine Hydrolysate($M) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Scientist HomeE Mixed Inositol($M) | 0.01 | |||||||||
Scientist Home Vein Cream($M) | 0.00 | 0.00 | 0.01 | 0.01 | ||||||
New Fiber Research($M) | 0.00 | |||||||||
Inversion Study($M) | 0.00 | |||||||||
Prostate Health Research($M) | 0.00 | |||||||||
Scientist Home Calcification Cream($M) | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
Vascular Study($M) | 0.00 | |||||||||
Scientist Home Spermaceti Cream($M) | 0.00 | 0.00 | 0.00 | |||||||
Mixed Taurine($M) | 0.00 | |||||||||
Recurrence Research($M) | 0.00 | |||||||||
Thyroid research($M) | 0.00 | |||||||||
Retail Trading Business($M) | 0.05 | 0.03 | 0.02 | 0.01 | 0.02 | |||||
Service Business($M) | 0.01 | |||||||||
Service Business($M) | 0.00 | -0.00 | 0.00 | |||||||
Retail Trading Business($M) | -0.10 | -0.10 | -0.15 | -0.05 | -0.04 | 0.01 | ||||
Non-Hong Kong($M) | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.01 | -0.00 | |||
Hong Kong($M) | -0.02 | -0.03 | 0.01 | |||||||
Service Business($M) | 0.00 | |||||||||
Retail Trading Business($M) | -0.10 | -0.15 | -0.05 | -0.04 | 0.01 | |||||
Retail Trading Business($M) | 0.51 | 0.54 | 0.62 | 0.72 | 0.11 | 0.02 | 0.02 | 0.05 | ||
Service Business($M) | 0.02 | 0.02 | 0.02 | |||||||
Earlier reporting (last reported 2026)2 | ||||||||||
Earlier reporting (last reported 2026)2 | ||||||||||
Earlier reporting (last reported 2026)2 | ||||||||||
Earlier reporting (last reported 2026)2 | ||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-10-30.
See a number that looks wrong?